Testing effectiveness (Phase 2)Ended earlyNCT04988087
What this trial is testing
Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)
Who this might be right for
Sjogren SyndromeMixed Connective Tissue Disease
Novartis Pharmaceuticals 30